TD Securities Raises Extendicare (EXE) Price Target to C$8.50

Share on StockTwits

Extendicare (TSE:EXE) had its price objective upped by equities researchers at TD Securities from C$8.00 to C$8.50 in a report released on Thursday, BayStreet.CA reports. The brokerage presently has a “hold” rating on the stock. TD Securities’ price target would suggest a potential upside of 5.59% from the company’s current price.

A number of other brokerages have also recently commented on EXE. CIBC lifted their price target on Extendicare from C$8.25 to C$8.50 in a research report on Thursday. Laurentian set a C$10.00 price objective on Extendicare and gave the company a “buy” rating in a research note on Tuesday, April 16th. Finally, Echelon Wealth Partners lowered Extendicare from a “buy” rating to a “hold” rating in a research note on Monday, March 4th. Three analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of C$8.40.

EXE traded up C$0.09 on Thursday, reaching C$8.05. 67,017 shares of the stock were exchanged, compared to its average volume of 263,734. Extendicare has a fifty-two week low of C$5.95 and a fifty-two week high of C$8.71. The company has a debt-to-equity ratio of 420.26, a quick ratio of 0.61 and a current ratio of 0.69. The stock has a market cap of $707.92 million and a P/E ratio of 22.49.

Extendicare (TSE:EXE) last issued its quarterly earnings results on Thursday, February 28th. The company reported C($0.09) EPS for the quarter, missing the Zacks’ consensus estimate of C$0.15 by C($0.24). The business had revenue of C$288.79 million during the quarter. Analysts predict that Extendicare will post 0.280000018500637 EPS for the current fiscal year.

Extendicare Company Profile

Extendicare Inc provides care and services for seniors in Canada. The company offers long term care services; retirement living services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management and consulting services to third-party owners.

Featured Story: How to identify percentage decliners

Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Cyberark Software  Receives New Coverage from Analysts at Cowen
Cyberark Software Receives New Coverage from Analysts at Cowen
BidaskClub Upgrades Cerner  to “Hold”
BidaskClub Upgrades Cerner to “Hold”
Kite Realty Group Trust  Downgraded by ValuEngine to “Strong Sell”
Kite Realty Group Trust Downgraded by ValuEngine to “Strong Sell”
Target  Upgraded at Citigroup
Target Upgraded at Citigroup
Synlogic  Downgraded to “Sell” at Citigroup
Synlogic Downgraded to “Sell” at Citigroup
Trevi Therapeutics  Stock Rating Lowered by Zacks Investment Research
Trevi Therapeutics Stock Rating Lowered by Zacks Investment Research


 
© 2006-2019 Zolmax.